Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Shire and HydroMed realign histrelin agreement

Jan. 7, 2002

Kyowa Hakko and Lilly report new potent antitumor compounds

Jan. 4, 2002

New dosage form of Atrix's Leuprogel licensed in by Sanofi-Synthelabo

Jan. 4, 2002

Japanese researchers identify new steroid sulfatase inhibitors

Jan. 2, 2002

Sterol derivatives claimed as antiproliferative and antiangiogenic agents

Jan. 2, 2002

ImClone's BLA filing for Erbitux not accepted by FDA

Jan. 2, 2002

ABX-EGF enters phase II trial for colorectal cancer

Jan. 2, 2002

Preliminary preclinical data demonstrate tumor vascular targeting efficacy of OXI-4503

Dec. 31, 2001

Novel epothilone derivatives from Schering act as microtubule-stabilizing agents

Dec. 31, 2001

Schering discloses new series of antiangiogenic agents

Dec. 31, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...